Acrivon Total Assets from 2010 to 2024

ACRV Stock

7.16 0.61 9.31%

Acrivon Therapeutics, Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 117.8 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

138.3 M

Current Value

117.8 M

Quarterly Volatility

63.1 M

Credit Downgrade

Yuan Drop

Covid

Check Acrivon Therapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Acrivon Therapeutics,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 479.9 K, Selling General Administrative of 22.1 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.94. Acrivon financial statements analysis is a perfect complement when working with Acrivon Therapeutics, Valuation or Volatility modules.

Check out the analysis of Acrivon Therapeutics, Correlation against competitors.

Latest Acrivon Therapeutics,'s Total Assets Growth Pattern

Below is the plot of the Total Assets of Acrivon Therapeutics, Common over the last few years. Total assets refers to the total amount of Acrivon Therapeutics, assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Acrivon Therapeutics, books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Acrivon Therapeutics,'s Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Acrivon Therapeutics,'s overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 138.26 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Acrivon Total Assets Regression Statistics

	Arithmetic Mean	37,859,022
	Geometric Mean	6,537,972
	Coefficient Of Variation	166.67
	Mean Deviation	52,321,898
	Median	2,185,000
	Standard Deviation	63,100,892
	Sample Variance	3981.7T
	Range	179M
	R-Value	0.74
	Mean Square Error	1916T
	R-Squared	0.55
	Significance	0
	Slope	10,494,301
	Total Sum of Squares	55744.1T

Acrivon Total Assets History

	2024	117.8 M
	2023	138.3 M
	2022	181.2 M
	2021	106.6 M

Other Fundumenentals of Acrivon Therapeutics,

Intangibles To Total Assets

Acrivon Therapeutics, Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Current Deferred Revenue	Capital Surpluse
Total Assets		0.87	0.84	-0.68	-0.81	0.69	0.39	0.87	-0.53	0.99	0.9	0.99	0.96	0.9	0.78	0.7	-0.53
Total Stockholder Equity	0.87		0.92	-0.23	-0.78	0.63	-0.11	1.0	-0.48	0.82	0.98	0.81	0.91	0.98	0.36	0.73	-0.48
Net Tangible Assets	0.84	0.92		-0.3	-0.95	0.87	-0.04	0.92	-0.79	0.83	0.95	0.82	0.92	0.95	0.44	0.89	-0.79
Net Debt	-0.68	-0.23	-0.3		0.44	-0.43	-0.94	-0.23	0.29	-0.74	-0.34	-0.75	-0.56	-0.34	-0.99	-0.32	0.29
Retained Earnings	-0.81	-0.78	-0.95	0.44		-0.97	-0.14	-0.78	0.88	-0.85	-0.88	-0.83	-0.91	-0.88	-0.57	-0.96	0.88
Accounts Payable	0.69	0.63	0.87	-0.43	-0.97		0.18	0.63	-0.94	0.75	0.75	0.73	0.81	0.75	0.55	0.95	-0.94
Total Liab	0.39	-0.11	-0.04	-0.94	-0.14	0.18		-0.11	-0.09	0.46	0.0	0.47	0.24	0.0	0.88	0.02	-0.09
Net Invested Capital	0.87	1.0	0.92	-0.23	-0.78	0.63	-0.11		-0.48	0.82	0.98	0.81	0.91	0.98	0.36	0.73	-0.48
Short Long Term Debt	-0.53	-0.48	-0.79	0.29	0.88	-0.94	-0.09	-0.48		-0.57	-0.57	-0.55	-0.61	-0.57	-0.41	-0.81	1.0
Total Current Assets	0.99	0.82	0.83	-0.74	-0.85	0.75	0.46	0.82	-0.57		0.88	1.0	0.97	0.88	0.83	0.75	-0.57
Capital Stock	0.9	0.98	0.95	-0.34	-0.88	0.75	0.0	0.98	-0.57	0.88		0.87	0.97	1.0	0.47	0.85	-0.57
Net Working Capital	0.99	0.81	0.82	-0.75	-0.83	0.73	0.47	0.81	-0.55	1.0	0.87		0.96	0.87	0.83	0.73	-0.55
Short Term Debt	0.96	0.91	0.92	-0.56	-0.91	0.81	0.24	0.91	-0.61	0.97	0.97	0.96		0.97	0.67	0.86	-0.61
Common Stock	0.9	0.98	0.95	-0.34	-0.88	0.75	0.0	0.98	-0.57	0.88	1.0	0.87	0.97		0.47	0.85	-0.57
Property Plant Equipment	0.78	0.36	0.44	-0.99	-0.57	0.55	0.88	0.36	-0.41	0.83	0.47	0.83	0.67	0.47		0.43	-0.41
Current Deferred Revenue	0.7	0.73	0.89	-0.32	-0.96	0.95	0.02	0.73	-0.81	0.75	0.85	0.73	0.86	0.85	0.43		-0.81
Capital Surpluse	-0.53	-0.48	-0.79	0.29	0.88	-0.94	-0.09	-0.48	1.0	-0.57	-0.57	-0.55	-0.61	-0.57	-0.41	-0.81

Click cells to compare fundamentals

About Acrivon Therapeutics, Financial Statements

Acrivon Therapeutics, investors use historical fundamental indicators, such as Acrivon Therapeutics,'s Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Acrivon Therapeutics,. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	138.3 M	117.8 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Acrivon Stock Analysis

When running Acrivon Therapeutics,'s price analysis, check to measure Acrivon Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrivon Therapeutics, is operating at the current time. Most of Acrivon Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Acrivon Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acrivon Therapeutics,'s price. Additionally, you may evaluate how the addition of Acrivon Therapeutics, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC